Compumedics Ltd
ASX:CMP

Watchlist Manager
Compumedics Ltd Logo
Compumedics Ltd
ASX:CMP
Watchlist
Price: 0.45 AUD 23.29%
Market Cap: AU$89.9m

Compumedics Ltd
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Compumedics Ltd
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Compumedics Ltd
ASX:CMP
Research & Development
-AU$1.3m
CAGR 3-Years
31%
CAGR 5-Years
19%
CAGR 10-Years
12%
Somnomed Ltd
ASX:SOM
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Cyclopharm Ltd
ASX:CYC
Research & Development
-AU$443.9k
CAGR 3-Years
6%
CAGR 5-Years
37%
CAGR 10-Years
-36%
Cochlear Ltd
ASX:COH
Research & Development
-AU$291.5m
CAGR 3-Years
-11%
CAGR 5-Years
-10%
CAGR 10-Years
-9%
Austco Healthcare Ltd
ASX:AHC
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
EMvision Medical Devices Ltd
ASX:EMV
Research & Development
-AU$4m
CAGR 3-Years
-20%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
No Stocks Found

Compumedics Ltd
Glance View

Market Cap
89.9m AUD
Industry
Health Care

Compumedics Ltd. is engaged in the research, development, manufacture and distribution of medical equipment. The company is headquartered in Melbourne, Victoria. The company went IPO on 2000-12-21. The firm is engaged in development, manufacture and commercialization of diagnostics technology for the sleep, brain and ultrasonic blood-flow monitoring applications. The firm sells all its product offerings, including sleep diagnostic systems, clinical EEG systems, brain monitoring systems, ultra-sonic blood-flow systems, supplies and technical service and support. The firm sell its products throughout America’s, Australia and Asia Pacific, and Europe and the Middle East regions. Its United States business also includes sleep diagnostic services business. The firm product includes ONsight A.V.S., Grael PSG, Grael LT EEG System, Siesta 802, Grael 4K PSG:EEG, Grael 4K-EEG, Neuvo 64-512 Channel LTM EEG and CURRY. The Company’s subsidiaries include Compumedics USA Ltd, DWL USA Inc., Compumedics USA Inc, Compumedics Telemed Pty Ltd, Compumedics Medical Innovation Pty Ltd, Compumedics Cardiology Pty Ltd.

CMP Intrinsic Value
0.52 AUD
Undervaluation 14%
Intrinsic Value
Price

See Also

What is Compumedics Ltd's Research & Development?
Research & Development
-1.3m AUD

Based on the financial report for Jun 30, 2025, Compumedics Ltd's Research & Development amounts to -1.3m AUD.

What is Compumedics Ltd's Research & Development growth rate?
Research & Development CAGR 10Y
12%

Over the last year, the Research & Development growth was 77%. The average annual Research & Development growth rates for Compumedics Ltd have been 31% over the past three years , 19% over the past five years , and 12% over the past ten years .

Back to Top